Scinai Immunotherapeutics (SCNI) Debt Ratio (2018 - 2025)

Scinai Immunotherapeutics has disclosed Debt Ratio across 8 years of filings, most recently posting 0.0 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.0, down 99.92% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0 (down 99.92% YoY), and the FY2025 annual result was 0.0, down 99.92% from the prior year.
• Debt Ratio came in at 0.0 for Q4 2025 at Scinai Immunotherapeutics, down from 0.07 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.36 in Q2 2024 to a low of 0.0 in Q4 2025.
• The 5-year median for Debt Ratio is 0.86 (2021), against an average of 0.73.
• Across the five-year window, Debt Ratio slumped 99.98% in 2021 and jumped 77.2% in 2023, its largest moves.
• Scinai Immunotherapeutics' Debt Ratio stood at 0.86 in 2021, then retreated by 12.05% to 0.76 in 2022, then jumped by 49.62% to 1.13 in 2023, then plunged by 95.5% to 0.05 in 2024, then tumbled by 99.92% to 0.0 in 2025.
• The last three Debt Ratio figures came in at 0.0 (Q4 2025), 0.07 (Q2 2025), and 0.05 (Q4 2024), per Business Quant data.